Coordinated expression of tyro3, axl, and mer receptors in macrophage ontogeny.
The TAM receptors (Tyro3, Axl, and Mer) are a family of homologous receptor-tyrosine kinases that inhibit Toll-like receptor signaling to regulate downstream pathways and restore homeostasis. TAM triple mutant mice (Tyro3-/-, Axl-/-, Mer-/-) have elevated levels of pro-inflammatory cytokines and are prone to developing lymphoproliferative disorders and autoimmunity. Understanding differential expression of TAM receptors among human subjects is critical to harnessing this pathway for therapeutic interventions. We have quantified changes in TAM expression during the ontogeny of human macrophages using paired samples of monocytes and macrophages to take advantage of characteristic expression within an individual. No significant differences in levels of Tyro3 were found between monocytes and macrophages (flow cytometry: p=0.652, immunoblot: p=0.231, qPCR: p=0.389). Protein levels of Axl were reduced (flow cytometry: p=0.049, immunoblot: p<0.001) when monocytes matured to macrophages. No significant differences in the levels of Axl mRNA transcripts were found (qPCR: p=0.082), however, Tyro3 and Axl were proportionate. The most striking difference was upregulation of expression of Mer with both protein and mRNA being significantly increased when monocytes developed into macrophages (flow cytometry: p<0.001, immunoblot: p<0.001, qPCR: p=0.004). A fuller characterization of TAM receptor expression in macrophage ontogeny informs our understanding of their function and potential therapeutic interventions.
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, 06519, USA.
Anna
A
Malawista
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, 06519, USA.
Xiaomei
X
Wang
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, 06519, USA.
Mark
M
Trentalange
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, 06519, USA.
Heather G
HG
Allore
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, 06519, USA; Program on Human Translational Immunology, Yale University School of Medicine, New Haven, CT, 06519, USA.
Ruth R
RR
Montgomery
Axl; Gas6; Macrophage; Mer; Monocyte; Protein S; TAM; TLR; Tyro3
J Virol. 2008 Aug;82(15):7613-23
18508883
J Leukoc Biol. 2002 Oct;72(4):621-7
12377929
Nat Rev Immunol. 2008 May;8(5):327-36
18421305
Nat Immunol. 2016 Apr;17(4):461-8
26878114
J Clin Invest. 2009 Oct;119(10):2942-53
19729839
J Immunol. 2015 Feb 15;194(4):1928-37
25567680
Nat Immunol. 2014 Oct;15(10 ):920-8
25194421
Annu Rev Immunol. 2006;24:353-89
16551253
J Thromb Haemost. 2010 Apr;8(4):838-44
20088931
Am J Respir Cell Mol Biol. 2005 Feb;32(2):108-17
15563692
Nat Immunol. 2016 Jan;17(1):34-40
26681460
Oncotarget. 2015 Mar 30;6(9):6722-36
25762638
Nat Immunol. 2012 Nov;13(11):1118-28
23023392
J Immunol. 2009 Sep 1;183(5):3004-13
19657094
Cell. 1995 Feb 24;80(4):661-70
7867073
Adv Cancer Res. 2008;100:35-83
18620092
J Biol Chem. 2014 Sep 12;289(37):25750-63
25074926
Aging (Albany NY). 2014 Feb;6(2):131-9
24595889
Cancer Res. 2010 Feb 15;70(4):1544-54
20145120
Elife. 2014 Sep 29;3:null
25265470
Nat Rev Immunol. 2006 Nov;6(11):823-35
17063184
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1896-901
12578971
Immunity. 2003 Jul;19(1):71-82
12871640
Nat Immunol. 2004 Oct;5(10):987-95
15454922
Nature. 2002 Dec 19-26;420(6917):846-52
12490957
J Immunol. 2008 Feb 15;180(4):2522-30
18250462
Mol Cancer Ther. 2011 Oct;10 (10 ):1763-73
21933973
Nat Immunol. 2001 Aug;2(8):675-80
11477402
Annu Rev Immunol. 2015;33:355-91
25594431